Literature DB >> 2185689

Amphotericin B: delivery systems.

J Brajtburg1, W G Powderly, G S Kobayashi, G Medoff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2185689      PMCID： PMC171600          DOI： 10.1128/AAC.34.3.381

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  28 in total

Review 1.  Amphotericin B: current understanding of mechanisms of action.

Authors:  J Brajtburg; W G Powderly; G S Kobayashi; G Medoff
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

2.  Effects of serum lipoproteins on damage to erythrocytes and Candida albicans cells by polyene antibiotics.

Authors:  J Brajtburg; S Elberg; G S Kobayashi; G Medoff
Journal:  J Infect Dis       Date:  1986-03       Impact factor: 5.226

3.  Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B.

Authors:  G Lopez-Berestein; R Mehta; R L Hopfer; K Mills; L Kasi; K Mehta; V Fainstein; M Luna; E M Hersh; R Juliano
Journal:  J Infect Dis       Date:  1983-05       Impact factor: 5.226

4.  Application of differential spectra in the ultraviolet-visible region to study the formation of amphotericin B-sterol complexes.

Authors:  I Gruda; P Nadeau; J Brajtburg; G Medoff
Journal:  Biochim Biophys Acta       Date:  1980-11-04

5.  Interaction of plasma proteins and lipoproteins with amphotericin B.

Authors:  J Brajtburg; S Elberg; J Bolard; G S Kobayashi; R A Levy; R E Ostlund; D Schlessinger; G Medoff
Journal:  J Infect Dis       Date:  1984-06       Impact factor: 5.226

6.  Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study.

Authors:  G Lopez-Berestein; V Fainstein; R Hopfer; K Mehta; M P Sullivan; M Keating; M G Rosenblum; R Mehta; M Luna; E M Hersh
Journal:  J Infect Dis       Date:  1985-04       Impact factor: 5.226

7.  Liposomal amphotericin B is toxic to fungal cells but not to mammalian cells.

Authors:  R Mehta; G Lopez-Berestein; R Hopfer; K Mills; R L Juliano
Journal:  Biochim Biophys Acta       Date:  1984-03-14

8.  Treatment of murine cryptococcosis with liposome-associated amphotericin B.

Authors:  J R Graybill; P C Craven; R L Taylor; D M Williams; W E Magee
Journal:  J Infect Dis       Date:  1982-05       Impact factor: 5.226

9.  Effect of the polar head structure of polyene macrolide antifungal antibiotics on the mode of permeabilization of ergosterol- and cholesterol-containing lipidic vesicles studied by 31P-NMR.

Authors:  B Cybulska; M Herve; E Borowski; C M Gary-Bobo
Journal:  Mol Pharmacol       Date:  1986-03       Impact factor: 4.436

10.  Effects of elevation of serum cholesterol and administration of amphotericin B complexed to lipoproteins on amphotericin B-induced toxicity in rabbits.

Authors:  M H Koldin; G S Kobayashi; J Brajtburg; G Medoff
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191
View more
  35 in total

Review 1.  In vitro models for studying toxicity of antifungal agents.

Authors:  V Joly; J Bolard; P Yeni
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

2.  Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani.

Authors:  Bidyut Purkait; Ashish Kumar; Nilay Nandi; Abul Hasan Sardar; Sushmita Das; Sudeep Kumar; Krishna Pandey; Vidyananda Ravidas; Manish Kumar; Tripti De; Dharmendra Singh; Pradeep Das
Journal:  Antimicrob Agents Chemother       Date:  2011-11-28       Impact factor: 5.191

3.  In search of the amazing technicolour dream coat for amphotericin B.

Authors:  J Conly; S Shafran
Journal:  Can J Infect Dis       Date:  1996-07

4.  Comparative in vitro effects of liposomal amphotericin B, amphotericin B-deoxycholate, and free amphotericin B against fungal strains determined by using MIC and minimal lethal concentration susceptibility studies and time-kill curves.

Authors:  E D Ralph; A M Khazindar; K R Barber; C W Grant
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

Review 5.  Liposomes and nanoparticles as vehicles for antibiotics.

Authors:  J Kreuter
Journal:  Infection       Date:  1991       Impact factor: 3.553

Review 6.  Amphotericin B: current understanding of mechanisms of action.

Authors:  J Brajtburg; W G Powderly; G S Kobayashi; G Medoff
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

7.  Dose-dependent antifungal activity and nephrotoxicity of amphotericin B colloidal dispersion in experimental pulmonary aspergillosis.

Authors:  M C Allende; J W Lee; P Francis; K Garrett; H Dollenberg; J Berenguer; C A Lyman; P A Pizzo; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

8.  Comparative pharmacokinetics of amphotericin B after administration of a novel colloidal delivery system, ABCD, and a conventional formulation to rats.

Authors:  R M Fielding; P C Smith; L H Wang; J Porter; L S Guo
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

9.  Pharmacokinetics of conventional formulation versus fat emulsion formulation of amphotericin B in a group of patients with neutropenia.

Authors:  A Ayestarán; R M López; J B Montoro; A Estíbalez; L Pou; A Julià; A López; B Pascual
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

10.  Management of deep Candida infection in surgical and intensive care unit patients. British Society for Antimicrobial Chemotherapy Working Party.

Authors: 
Journal:  Intensive Care Med       Date:  1994-08       Impact factor: 17.440
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.